Morningstar Investor users sign in here.

Stocks

What's dragging down small growth?

As the value rotation continues, US healthcare and tech names lag.


As the rotation of investor dollars from fast-growing company stocks into value names continued in May, small-growth names have been left in the dust.

Last month, losses in biotech and solar stocks led broader declines in small-cap health care and technology shares. Meanwhile, the rebound in energy stocks--a group which no longer can count any names in the small-growth bucket--has contributed to the group’s lagging performance.

Small growth, which was a 2020 Morningstar Style Box leader with 43.5% return, is now the bottom-performing grouping in the U.S. stock market. The Morningstar US Small Growth Index dropped by 4.80% in one month alone, taking it into negative territory for 2021 returns through the end of May. Morningstar defines small-cap growth stocks as high-growth companies with less than about $2 billion in capitalisation.

May’s return profile for U.S. stocks marks a continued shift in leadership among style that began late in 2020. 

Style box performance

So what happened?

Healthcare and technology were among the biggest detractors within small growth during May, losing 13% and 3%, respectively. Only the basic materials sector saw positive returns in the month. All small-growth sectors except for utilities and consumer cyclical lagged the broader market.

May 2021 Sector Performance

The struggles for healthcare and tech stocks reflect the broader change seen in the stock market in recent months. Before the tide turned toward value and away from growth in October 2020, healthcare was the top-performing sector, growing over 32% in the first three quarters of 2020. For 2020 as a whole, the small-growth space saw big gains in all sectors except energy, which tanked. Technology grew 53% in 2020 and healthcare grew 61%.

Small growth serctor performance

 

 

Drilling down to the industry level, groups within healthcare and technology dragged performance down more than others. Biotechnology lost over 12% in May alone, and solar power saw losses of nearly 32%.

Small Growth leading detractors

Growth stocks tend to have strong businesses, but they often come with rich valuations that could collapse if they fall short of expectations. Meanwhile, small-growth firms tend to be less profitable and face greater uncertainty than better-established growth stocks. They carry the greatest growth potential but this combination also makes for greater volatility.

At the individual stock level, healthcare company ChemoCentryx (CCXI) was the leading detractor with a loss of 78%. Fellow healthcare names Iovance (IOVA) and Natera (NTRA) also pulled returns down for the month of May.

But strong returns on these stocks over three- and five-year performance periods for these companies illustrate the changing sector trends. For example, ChemoCentryx is up more than 13% a year for the last five years, for a cumulative return of 82%. Iovance and Natera had performance runs of over 25% and 46% a year for the last five years, respectively.

Small Growth leading detractors

Another example can be found in Plug Power (PLUG), a “meme stock” featured on reddit.com's speculative discussion platform wallstreetbets. Morningstar Direct’s performance attribution analysis tool shows that Plug Power has been the No. 1 contributor to the small growth index’s performance. An 86% rally in Plug Power in January 2021 vaulted the stock to an 1850% cumulative return since the start of 2020. But since the end of January, the stock has fallen back by more than 50% through the end of May.

On the flip side, energy companies--which are currently leading the market--are notably absent from the ranks of small-growth companies. Energy representation has steadily decreased since 2017, and as of last year’s end, the Morningstar US Small Cap Growth Index holds zero energy names.

Small cap growth sector composition

 

 

Small growth’s underperformance over the past month is part of a bigger trend: the market rotation from growth into value. Value is coming up as a clear leader: Small- and mid-cap value are the year’s current leaders, each earning over 24% year to date. This is a flip-flop compared with three- and five-year performance periods, when large- and mid-growth names led the market.

Historical market performance


© 2023 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. This report has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or New Zealand wholesale clients of Morningstar Research Ltd, subsidiaries of Morningstar, Inc. Any general advice has been provided without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide at www.morningstar.com.au/s/fsg.pdf. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Our publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Morningstar’s full research reports are the source of any Morningstar Ratings and are available from Morningstar or your adviser. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a financial adviser. Some material is copyright and published under licence from ASX Operations Pty Ltd ACN 004 523 782.

More from Morningstar

This five-star Aussie stock has a wide moat
Stocks

This five-star Aussie stock has a wide moat

Our analysts believe it can protect and grow its earnings for at least the next 20 years
Despite rally this A-REIT remains undervalued
Stocks

Despite rally this A-REIT remains undervalued

While attractive from a valuation standpoint we do not believe this A-REIT warrants a moat and is highly leveraged.
We advise waiting for a pullback before investing in the world's biggest company
Stocks

We advise waiting for a pullback before investing in the world's biggest company

We’ve raised our fair value estimate and sales forecast, but still see the stock as rich.
7 charts on the AI stock boom one year after ChatGPT’s launch
Stocks

7 charts on the AI stock boom one year after ChatGPT’s launch

These stocks and the key trends behind them are critical for understanding the AI investment landscape.
Why Berkshire Hathaway’s success will continue after Charlie Munger ... and Warren Buffett
Stocks

Why Berkshire Hathaway’s success will continue after Charlie Munger ... and Warren Buffett

Munger’s passing is a spiritual loss for the company.
Morningstar initiates coverage on 3 new shares
Stocks

Morningstar initiates coverage on 3 new shares

There are 2 undervalued names as part of our new coverage.